Medical News

RSS

Electromed first quarter net revenues increase 29.1% to $5.38 million

Electromed, Inc. today announced financial results for the three-month period ended September 30, 2011. Net Revenues for the three months ended September 30, 2011 were approximately $5,379,000, a 29.1% increase compared to Net Revenues of approximately $4,165,000 for the same period last year.

8 Nov 2011

Kessler Foundation neuropsychologists receive National Multiple Sclerosis Society grants

Two neuropsychologists at Kessler Foundation Research Center were awarded more than $100,000 in grants by the National Multiple Sclerosis Society. Nancy Chiaravalloti, PhD, received $63,000 to conduct a pilot study, "Speed of Processing Training for Improving Processing Speed in Persons with MS".

8 Nov 2011

Bioject third quarter revenues increase to $3.1 million

Bioject Medical Technologies Inc., a leading developer of needle-free drug delivery systems, today reported financial results for the third quarter ended September 30, 2011.

8 Nov 2011

Higher protein load in critical brain regions linked to severe depression in late life

Depression is one of the most common mental disorders in the elderly, but little is known about the underlying biology of its development in older adults.

8 Nov 2011

Premier, RF Surgical sign three year agreement for detection technology

RF Surgical, Inc., the leader in prevention and detection of retained surgical items (RSI), today announced a three year agreement with the Premier healthcare alliance, a leader in healthcare performance improvement.

8 Nov 2011

Many parents still place their infants in unsafe sleep settings

The nearly two-decades-long national "back to sleep" campaign that promotes infant safe sleep is credited with reducing the rate of sudden infant death syndrome in the United States.

8 Nov 2011

Lapatinib drug could also treat head and neck cancers

A class of drugs used to treat breast cancers which overproduce a protein called HER2 could also treat other types of cancer - particularly head and neck cancers, according to research presented at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool this week.

8 Nov 2011

Pennsylvania General Assembly passes bill banning texting for all drivers

The National Safety Council congratulates the Pennsylvania General Assembly for passage of Senate Bill 314, which makes sending text messages while driving a violation for all drivers. The bill will become law with Gov. Tom Corbett's signature, and the law will go into effect 120 days after it is signed.

8 Nov 2011

Antares Pharma third quarter total revenues increase 26% to $3.9M

Antares Pharma, Inc. today reported financial and operating results for the third quarter ended September 30, 2011.

8 Nov 2011

UC Santa Barbara's ImmuNet project focuses on targeted immunizations for infants, children

The University of California, Santa Barbara announced today that it will receive funding through Grand Challenges Explorations, an initiative created by the Bill & Melinda Gates Foundation that enables researchers worldwide to test unorthodox ideas that address persistent health and development challenges. Professors Elizabeth Belding and Amr El Abbadi in the Computer Science Department will pursue an innovative global health research project, titled "ImmuNet: Targeted Immunizations for Infants and Children".

8 Nov 2011

Health Net expands Improving the Patient Experience toolkit

Health Net, Inc. has expanded its Improving the Patient Experience toolkit for its contracted providers in three new markets. Piloted first in California in 2010, the insurer now offers the toolkit in Arizona, Oregon and Washington.

8 Nov 2011

BioScrip third quarter revenue increases 2.9% to $454.0 million

BioScrip, Inc. today announced 2011 third quarter financial results. Revenue for the three months ended September 30, 2011 was $454.0 million and net income was $0.5 million, or $0.01 per diluted share, including $5.0 million in restructuring charges, severance and other employee costs.

8 Nov 2011

FDA grants Fast Track designation to Opexa's Tovaxin for treatment of SPMS

Opexa Therapeutics, Inc., announced today that its lead drug candidate Tovaxin® has been granted Fast Track designation by the U.S. Food and Drug Administration (FDA) for the treatment of patients with Secondary Progressive Multiple Sclerosis.

8 Nov 2011

Comprehend Systems closes $1.2 million seed round funding

Driven by increasing demand from drug and medical device developers for cost-effective and user-friendly data analytics tools, Comprehend Systems, Inc. closed $1.2 million in seed round funding to support further development of Comprehend Clinical, its clinical data visualization and analytics software.

8 Nov 2011

Cordis receives FDA 510(k) clearance for EMPIRA Balloon Catheters

Cordis Corporation today announced EMPIRA and EMPIRA NC RX PTCA Dilatation Catheters have received 510(k) regulatory clearance for the treatment of coronary artery disease.

8 Nov 2011

Salix enters definitive agreement to acquire Oceana Therapeutics

Salix Pharmaceuticals, Ltd. and Oceana Therapeutics, LLC today announced that they have entered into a definitive agreement whereby Salix will acquire all of the outstanding stock of Oceana Therapeutics, Inc., a privately-held global provider of gastroenterology and urology therapeutics, for $300 million in cash.

8 Nov 2011

Celldex Therapeutics initiates CDX-1127 Phase 1 study in malignant solid tumors

Celldex Therapeutics, Inc. today announced initiation of a Phase 1 study of its therapeutic human antibody candidate, CDX-1127, in patients with selected malignant solid tumors or hematologic cancers.

8 Nov 2011

CardioNet third quarter revenue decreases 3.2% to $26.6 million

CardioNet, Inc., a leading wireless medical technology company with a current focus on the diagnosis and monitoring of cardiac arrhythmias, today reported results for the third quarter ended September 30, 2011.

8 Nov 2011

First Edition: November 8, 2011

Today's early morning highlights from the major news organizations, including stories on malpractice reforms and previews of voting in Ohio on two ballot questions affecting health care issues and a Mississippi abortion issue.

8 Nov 2011

New breast and ovarian cancer vaccine in the pipeline: Study

A new vaccine is being tried clinically to combat tumor cells in a small study of advanced breast and ovarian cancer patients. The results show that there is improvement in overall survival times and stopping the disease for a handful of breast cancer patients.

8 Nov 2011